Wells Fargo's Brian Abrahams likes the news on Vertex (VRTX), saying it cleanly validates the efficacy of it's corrector/potentiator approach, and meaningfully increases the likelihood of success in its '809/Kalydeco Phase III program, and at worst gives VRTX a high probability shot for '661/Kalydeco to capture this multi-billion dollar opportunity. As such, Abrahams sees significant upside potential from the news.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs